Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$142M |
| 2 |
Procter & Gamble
PG
|
+$74.5M |
| 3 |
PepsiCo
PEP
|
+$60.9M |
| 4 |
Pinduoduo
PDD
|
+$58.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$56.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$565M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$337M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$335M |
| 4 |
Walmart Inc
WMT
|
+$314M |
| 5 |
Danaher
DHR
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.98% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Healthcare | 17.12% |
| 4 | Industrials | 3.53% |
| 5 | Financials | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Integra LifeSciences
IART
$1.34B
| $5.42M | 0.03% |
80,981
+6,018
| +8% | +$407K |
|
277
Edgewell Personal Care
EPC
$1.31B
| $5.42M | 0.03% |
118,547
+24,752
| +26% | +$999K |
|
278
Legend Biotech
LEGN
$4.01B
| $5.41M | 0.03% |
+116,159
| New | +$5.89M |
|
279
Neogen
NEOG
$2.5B
| $5.41M | 0.03% |
119,049
+19,806
| +20% | +$847K |
|
|
FITB
280
Fifth Third Bancorp
FITB
$51.8B
| $5.35M | 0.03% |
122,848
-149,399
| -55% | -$6.54M |
|
|
PINC
281
DELISTED
Premier
PINC
| $5.33M | 0.03% |
129,492
+16,175
| +14% | +$638K |
|
282
Leggett & Platt
LEG
$1.31B
| $5.28M | 0.03% |
128,319
-74,772
| -37% | -$3.25M |
|
283
Willis Towers Watson
WTW
$32B
| $5.25M | 0.03% |
22,089
+14,272
| +183% | +$3.38M |
|
284
General Dynamics
GD
$106B
| $5.25M | 0.03% |
+25,158
| New | +$5.08M |
|
285
RELX
RELX
$62B
| $5.24M | 0.03% |
160,808
-8,181
| -5% | -$255K |
|
286
Cintas
CTAS
$81.3B
| $5.24M | 0.03% |
47,316
+35,712
| +308% | +$3.85M |
|
287
ICU Medical
ICUI
$4.61B
| $5.24M | 0.03% |
22,087
+2,496
| +13% | +$583K |
|
288
QuidelOrtho
QDEL
$838M
| $5.23M | 0.03% |
38,738
-3,333
| -8% | -$464K |
|
289
Nu Skin
NUS
$267M
| $5.2M | 0.03% |
102,374
+16,218
| +19% | +$721K |
|
290
Archer Daniels Midland
ADM
$36.9B
| $5.19M | 0.03% |
+76,780
| New | +$4.96M |
|
291
U-Haul Holding Co
UHAL
$14.6B
| $5.18M | 0.03% |
71,280
-47,740
| -40% | -$3.44M |
|
292
Thor Industries
THO
$4.14B
| $5.17M | 0.03% |
49,872
-24,335
| -33% | -$2.64M |
|
293
Nutrien
NTR
$30.7B
| $5.17M | 0.03% |
68,631
+58,061
| +549% | +$4.06M |
|
294
Central Garden & Pet Co Class A
CENTA
$2.44B
| $5.04M | 0.03% |
131,730
+9,601
| +8% | +$355K |
|
295
Beyond Meat
BYND
$277M
| $5.04M | 0.03% |
77,322
+43,053
| +126% | +$3.66M |
|
296
Floor & Decor
FND
$6.68B
| $5.03M | 0.03% |
38,720
-11,604
| -23% | -$1.5M |
|
297
Graham Holdings Company
GHC
$5.02B
| $4.92M | 0.03% |
7,817
+5,014
| +179% | +$2.95M |
|
|
298
Danaher
DHR
$144B
| $4.92M | 0.03% |
16,864
-776,893
| -98% | -$214M |
|
299
Agilon Health
AGL
$1.6B
| $4.91M | 0.03% |
7,271
+928
| +15% | +$565K |
|
300
Medifast
MED
$141M
| $4.91M | 0.03% |
23,420
+3,044
| +15% | +$629K |
|
Similar funds
Ray Dalio's Q4 2021 Portfolio in Review
As of Q4 2021, Ray Dalio held 820 positions worth $17.2B, down 5.8% from $18.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ray Dalio withdrew a net $1.89B in Q4 2021, closing 89 positions and reducing 292 holdings. Its most notable exit was Ecolab, an estimated $14.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Ray Dalio opened a new position in RTX Corp worth $16M.
- Ray Dalio's largest Q4 2021 buy was RTX Corp: 186,232 shares worth $16M.
- Ray Dalio added most to Alibaba in Q4 2021, an estimated $142M increase.
- Ray Dalio's biggest Q4 2021 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $565M.
- Ray Dalio fully exited Ecolab in Q4 2021, selling an estimated $14.2M.
- Ray Dalio's ten largest holdings make up 36% of its $17.2B portfolio in Q4 2021.
- Ray Dalio opened 137 new positions and closed 89 in Q4 2021.
- Ray Dalio's portfolio value fell 5.8% quarter-over-quarter to $17.2B.
Based on Bridgewater Associates's 13F filing for Q4 2021, filed 14 Feb 2022.